Cargando…
Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention
OBJECTIVE: Although several clinical trials have shown that the mid- and long-term safety and efficacy of prasugrel are better than those of clopidogrel after percutaneous coronary intervention (PCI), there are few data regarding the short-term safety. METHODS: In this study, we retrospectively anal...
Autores principales: | Koyabu, Yota, Abe, Shichiro, Sakuma, Masashi, Kanaya, Tomoaki, Obi, Syotaro, Yoneda, Shuichi, Toyoda, Shigeru, Nakajima, Toshiaki, Inoue, Teruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746638/ https://www.ncbi.nlm.nih.gov/pubmed/31118376 http://dx.doi.org/10.2169/internalmedicine.2262-18 |
Ejemplares similares
-
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
por: Masuyama, Taiki, et al.
Publicado: (2020) -
Prediction of Acute-phase Complications in Patients with Infectious Endocarditis
por: Saito, Fumiya, et al.
Publicado: (2019) -
Serum adiponectin and TNFα concentrations are closely associated with epicardial adipose tissue fatty acid profiles in patients undergoing cardiovascular surgery
por: Sawaguchi, Tatsuya, et al.
Publicado: (2017) -
Heat induces myogenic transcription factors of myoblast cells via transient receptor potential vanilloid 1 (Trpv1)
por: Obi, Syotaro, et al.
Publicado: (2018) -
Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients
por: Nakajima, Toshiaki, et al.
Publicado: (2019)